Session 1: Tumor Microenvironment

  1. Abigail Overacre, University of Pittsburgh - NEUROPILIN-1 ENFORCES TREG STABILITY AND FUNCTION IN THE TUMOR MICROENVIRONMENT
  2. Colleen Netherby, Roswell Park Cancer Institute - INTERFERON REGULATORY FACTOR-8 (IRF8) RESTORES THE MYELOID BALANCE IN CANCER


Session 2:‚Äč Cell Therapies

  1. Joanne Hammill, McMaster University - A NOVEL XENOGRAFT MODEL OF CHIMERIC ANTIGEN RECEPTOR-MEDIATED OFF-TUMOR TOXICITY
  2. Christopher Helsenm, McMaster University - T-CELL ANTIGEN COUPLER (TAC) ENGINEERED T CELLS DEMONSTRATE EFFICACY AGAINST SOLID TUMORS


Session 3: Translational and Clinical Cancer Studies

  1. Jessica Chacon, University of Pennsylvania - FIRST IN-DEPTH INVESTIGATION OF MULTIPLE INHIBITORY MOLECULE EXPRESSION BY BONA FIDE TUMOR-REACTIVE T CELLS IN OVARIAN CANCER.
  2. Yeshavantha Kumar Bansavadi-Siddegowda, The Ohio State University - PRMT5-PTEN MOLECULAR PATHWAY REGULATES SENESCENCE AND SELF-RENEWAL OF GLIOBLASTOMA STEM-LIKE CELLS


Session 4: Tumor Microenvironment #2

  1. Jenessa Smith, University of Pennsylvania - FEASIBILITY AND SAFETY OF CCD20 RNA CAR-BEARING T CELL THERAPY FOR THE TREATMENT OF CANINE B CELL MALIGNANCIES
  2. Gary Kohanbash, University of Pittsburgh - IDH MUTATION-INDUCED SUPPRESSION OF TYPE-1 ANTI-GLIOMA IMMUNE RESPONSES


Session 5: Viral therapies/ Vaccines and Model Systems

  1. Heather Gibson, Karmanos Cancer Institute - IN SITU IMMUNE IMAGING TO MONITOR THE IMPACT OF IMMUNOTHERAPY
  2. Kellie Haworth, Nationwide Children's Hospital - ONCOLYTIC VIROTHERAPY ENHANCES GD2-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN GD2-EXPRESSING PEDIATRIC SOLID TUMOR XENOGRAFT MODELS      2. Keisuke Watanabe, University of Pennsylvania - ONCOLYTIC ADENOVIRUS ARMED WITH CYTOKINES ENHANCES CAR-T CELL EFFICACY IN PANCREATIC TUMOR MODEL


Session 6: Emerging Therapies

  1. Steven Jones, Karmanos Cancer Institute - FOLATE RECEPTOR TARGETED DELIVERY OF SIRNA AND PACLITAXEL TO OVARIAN CANCER CELLS VIA FOLATE CONJUGATED TRIBLOCK COPOLYMER TO OVERCOME TLR4 DRIVEN CHEMOTHERAPY RESISTANCE
  2. Mark Bucsek, Roswell Park Cancer Institute - ADRENERGIC SIGNALING MEDIATES IMMUNE SUPPRESSION INDUCED BY COOL HOUSING TEMPERATURES FOR LABORATORY MICE


Poster 

  1. Jenessa Smith, University of Pennsylvania - FEASIBILITY AND SAFETY OF CCD20 RNA CAR-BEARING T CELL THERAPY FOR THE TREATMENT OF CANINE B CELL MALIGNANCIES
  2. Colleen Netherby, Roswell Park Cancer Institute - INTERFERON REGULATORY FACTOR-8 (IRF8) RESTORES THE MYELOID BALANCE IN CANCER


Translational Research Cancer Centers Consortium

Expediting Progress in Cancer Immunotherapy

2016 Young Investigator Award Winners

2016 TRCCC Annual Meeting Photos

Translational Research Cancer Centers Consortium

Copyright Translational Research Cancer Centers Consortium

_________________________________________________________________________________